Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $10.40 (+1.56%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
LMRI vs Sector & Market
| Metric | LMRI | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 1.50 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +106.1% | +1710.8% | +16.4% |
| P/E Ratio | -13.09 | 3.31 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.05B | $1.06B | $1.07B | 6 |
| 2027-03-31 | $262M | $264M | $266M | 2 |
| 2027-06-30 | $276M | $279M | $281M | 2 |
| 2027-09-30 | $283M | $286M | $287M | 2 |
| 2027-12-31 | $293M | $296M | $298M | 2 |
| 2028-03-31 | $277M | $280M | $282M | 1 |
| 2028-06-30 | $290M | $293M | $295M | 1 |
| 2028-09-30 | $295M | $298M | $300M | 1 |
| 2028-12-31 | $303M | $306M | $308M | 1 |
| 2029-12-31 | $1.24B | $1.25B | $1.26B | 3 |
| 2030-12-31 | $1.31B | $1.32B | $1.33B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.70 | $0.73 | $0.75 | 5 |
| 2027-03-31 | $0.19 | $0.19 | $0.20 | 1 |
| 2027-06-30 | $0.23 | $0.23 | $0.23 | 1 |
| 2027-09-30 | $0.24 | $0.25 | $0.25 | 1 |
| 2027-12-31 | $0.29 | $0.29 | $0.29 | 1 |
| 2028-03-31 | $0.22 | $0.22 | $0.22 | 2 |
| 2028-06-30 | $0.24 | $0.24 | $0.24 | 2 |
| 2028-09-30 | $0.25 | $0.25 | $0.25 | 2 |
| 2028-12-31 | $0.27 | $0.27 | $0.27 | 2 |
| 2029-12-31 | $1.27 | $1.29 | $1.30 | 1 |
| 2030-12-31 | $1.43 | $1.45 | $1.46 | 1 |
Frequently Asked Questions
What is the analyst consensus for LMRI?
The consensus among 2 analysts covering Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is Strong Buy with an average price target of $22.57.
What is the highest price target for LMRI?
The highest analyst price target for LMRI is $23.00.
What is the lowest price target for LMRI?
The lowest analyst price target for LMRI is $22.00.
How many analysts cover LMRI?
2 analysts have issued ratings for Lumexa Imaging Holdings, Inc. Common Stock in the past 12 months.
Is LMRI a buy or sell right now?
Based on 2 analyst ratings, LMRI has a consensus rating of Strong Buy (1.50/5) with a +106.1% upside to the consensus target of $22.57.
What are the earnings estimates for LMRI?
Analysts estimate LMRI will report EPS of $0.73 for the period ending 2026-12-31, with revenue estimated at $1.06B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.